Cyclosporine A delays wound healing and apoptosis and suppresses activin βA expression in rats

European Journal of Dermatology

Volumn 8, Issue 2, 1998, Pages 104-113

  Petri, Jean Bernhard ^a   Schurk, Sebastian ^a   Gebauer, Silke ^a   Haustein, Uwe Frithjof ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Activin ; Apoptosis; Collagen gel contraction; Cyclosporine A; Extracellular matrix; Gene expression

Indexed keywords

ACTIVIN A; CALCINEURIN; CELL ADHESION MOLECULE; CYCLOSPORIN A; FIBRONECTIN; INTEGRIN; INTERLEUKIN 6; KERATINOCYTE GROWTH FACTOR; METALLOPROTEINASE; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CONNECTIVE TISSUE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GRANULATION TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; ORGAN TRANSPLANTATION; RAT; SCLERODERMA; SKIN FIBROBLAST; WOUND HEALING;

ACTIVINS; ANIMALS; APOPTOSIS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FIBROBLASTS; GRANULATION TISSUE; IMMUNOSUPPRESSIVE AGENTS; MALE; OLIGOPEPTIDES; PEPTIDES; RATS; RATS, WISTAR; TIME FACTORS; WOUND HEALING;

EID: 0031894138     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hess A, Colombani P. Cyclosporine A. Mechanism of action: in vitro studies. Prog Allergy 1986; 38: 198-221.
2. Ryffel B. Pharmacology of cyclosporine. VI. Cellular activation: regulation of intracellular events by cyclosporine. Pharmacological Reviews 1989; 41: 407-22.
3. Foxwell BMJ, Woerly G, Husi H, Mackie A, Quesniaux VFJ, Hiestand PC, Wenger RM, Ryffel B. Identification of several cyclosporine binding proteins in lymphoid and non-lympohoid cells in vivo. Biochem Biophys Acta 1992; 1138: 115-21.
4. Koletsky AJ, Harding MW, Handschumacher RE. Cyclophilin: distribution and variant properties in normal and neoplastic tissues. J Immunol 1986; 137: 1054-9.
5. + in fibroblast cells. FEBS Lett 1996; 39: 131-3.
6. Chaudhuri B, Stephan C. Only in the presence of immunophilins can cyclosporin and FK506 disrupt in vivo binding of calcineurin to its autoinhibitory domain yet strengthen interaction between calcineurin A and B subunits. Biochem Biophys Res Comm 1995; 215: 781-90.
7. Baldari C, Macchia G, Heguy A, Melli M, Telford JL. Cyclosporin A blocks calcium-dependent pathways gene activation. J Biol Chem 1992; 266: 19103-8.
8. Ryffel B. Cyclosporin binding proteins. Biochemical Pharmacology 1993; 46/1: 1-12.
9. Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, Fiorentino D, Nourse J, Crabtree G. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopath 1996; 80: S40-5.
10. Groenewegen G, Buurman WA, van der Linden CJ. Lymphokine dependence of in vivo expression of MHC class II antigens by endothelium. Nature 1985; 316: 361-3.
11. Furue M, Katz SI. The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro. J Immunol 1988; 140: 4139-43.
12. Furue M, Gaspari AA, Katz SI. The effect of cyclosporine A on epidermal cells. II. Cyclosporine A inhibits proliferation of normal and transformed keratinocytes. J Invest Dermatol 1988; 90: 796-800.
13. Urabe A, Kanitakis J, Viac J, Thivolet J. Cyclosporine A inhibits directly in vivo keratinocyte proliferation of living human skin. J Invest Dermatol 1989; 92: 755-7.
14. Damoiseaux JGMC, Beijleveld LJJ, Van Breda Vriesman PJC. Cutaneous immunopathology of cyclosporin-A-induced autoimmunity in the rat. Clin Immunol Immunopath 1995; 77: 315-23.
15. Columbo M, Bochner BS, Marone G. Human skin mast cells express functional β1 integrins that mediate adhesion to extracellular matrix proteins. J Immunol 1995; 154: 6058-64.
16. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996; 23: 165-75.
17. Bennett JA, Christian JM. Cyclosporine-induced gingival hyperplasia. A case report and literature review. J Am Dent Assoc 1985; 111: 272-3.
18. Willershausen-Zönnchen B, Lemmen C, Schumacher U. Influence of cyclosporine A on growth and extracellular matrix synthesis of human fibroblasts. J Cell Physiol 1992; 152: 397-402.
19. Wondimu B, Modeer T. Cyclosporin A upregulates prostaglandin E (2) production in human gingival fibroblasts challenged with tumor necrosis factor alpha in vitro. J Oral Pathology & Medicine 1997; 26/1: 11-6.
20. Tomono M, Toyoshima K, Ito M, Amano H. Calcineurin is essential for DNA synthesis in Swiss 3T3 fibroblasts. Biochem J 1996; 317: 675-80.
21. Remitz A, Reitamo S, Mauviel A, Kähäri VM, Tan E, Uitto J. Effect of cyclosporine A on type I collagen gene expression by cultured human fibroblasts and smooth muscle cells. J Invest Dermatol 1992; 98: 624 (abstract 436).
22. Keski-Oja J, Kähäri VM. Regulation of fibroblast collagenase expression by cyclosporine A. J Cell Biochem Suppl 1993; 17E: 155.
23. Lohi J, Kähäri VM, Keski-Oja J. Cyclosporine A enhances cytokine and phorbol ester-induced fibroblast collagenase expression. J Invest Dermatol 1994; 102: 938-44.
24. Frances C, Branchet M, Bletry O, Lefevre CH, Boisnic S, Kern P, Codeau P. Skin collagen from scleroderma patients before and after cyclosporine A treatment. Clin Exp Dermatology 1988; 13: 1-3.
25. Zachariae H, Halkier-Sorensen L, Heickendorff L, Zachariae E, Hansen H. Cyclosporine A treatment of systemic sclerosis. Br J Dermatol 1990; 122: 677-81.
26. Holt DW, Johnston A. Cyclosporin monitoring: its role in autoimmune indications. J of Autoimmunity 1992; 5/A: 177-82.
27. Gebauer S, Saalbach A, Mittag M, Neubauer H, Adelmann-Grill B, Petri JB, Herrmann K. Expression of adhesion molecules during wound healing - characterization of granulation fibroblasts. J. für Anästhesie und Intensivbehandlung. Current Aspects in Wound Healing J A I 1996, 3: 32-42.
28. Petri JB, Saalbach A, Pierer M, Haupt B, Haustein UF, Herrmann K. The course of wound healing: in vitro analysis of adhesion molecule expression and gel contraction with human granulation fibroblasts. Wound Rep Regen 1997; 5: 1-8.
29. Petri JB, König S, Haupt B, Haustein UF, Herrmann K. Molecular analysis of different phases in human wound healing. Exp Dermatology 1997b; 6: 1-7.
30. Frank S, Madlener M, Werner S. Transforming growth factors β1, β2 and β3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 1996; 271: 10188-93.
31. Hubner G, Werner S. Serum growth factors and proinflammatory cytokines are potent inducers of activin expression in cultured fibroblasts and keratinocytes. Exp Cell Res 1996; 228: 106-13.
32. Krieg T, Meurer M. Systemic scleroderma. Clinical and pathophysiological aspects. J Am Acad Dermatol 1988; 18: 457-84.
33. Tanimoto K, Yoshid E, Mita S, Nibu Y, Marakami K, Fukamizu A. Human activin βA gene. J Biol Chem 1996; 271: 32760-9.
34. Ohga E, Matsuse T, Teramoto S, Katayama H, Nagase T, Fukuchi Y, Ouchi Y. Effects on proliferation and differentiation of human lung fibroblasts. Biochem Biophys Res Comm 1996; 228: 391-6.
35. Fishel RS, Barbul A, Wasserkrug HL, Penberthy LT, Rettura G, Efron G. Cyclosporine A impairs wound healing in rats. J Surg Res 1983; 34: 572-5.
36. Mauviel A, Heino J, Kähäri VM, Hartmann DJ, Loyau G, Pujol JP, Vuorio E. Comparative effects of interleukin-1 and tumour necrosis factor-α on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol 1991; 96: 243-9.
37. Takeda K, Hatamochi A, Arakawa M, Ueki H. Effects of tumour necrosis factor-α on connective tissue metabolism in normal and scleroderma fibroblast cultures. Arch Dermatol Res 1992; 284: 440-4.
38. Mosieniak G, Figiel I, Kaminska B. Cyclosporin A, an immunosuppressive drug, induces programmed cell death in rat C6 glioma cells by a mechanism that involves the AP-1 transcription factor. J of Neurochemistry 1997; 68/3: 1142-9.
39. De Bleser PJ, Niki T, Xu G, Rogiers V, Geerts A. Localization and cellular sources of activins in normal and fibrotic rat liver. Hepatology 1997; 26: 905-12.
40. Taylor M, Ashcroft AT, Messenger AG. Cyclosporine A prolongs human hair growth in vitro. J Invest Dermatol 1993; 100: 237-9.
41. Paus R, Bottge JA, Henz BM, Maurer M. Hair growth control by immunosuppression. Arch Dermatol Res 1996; 288: 408-10.